UAMY's Revenue Triple May Expose Why Antimony Contracts Don't Guarantee Earnings—Or Do They
United States Antimony Corp (UAMY) is scheduled to report Q1 2026 earnings after market close on May 14, 2026 — just one day away. With the stock trading at $9.97 and analysts projecting a loss of $0.02 per share, investors face a critical question: can this small-cap antimony producer demonstrate operational progress after a challenging year marked by consistent earnings misses? The answer will determine whether UAMY can sustain its recent technical momentum or face another post-earnings selloff.
Part 1: Earnings Preview
United States Antimony Corp is a small-cap mining company focused on producing antimony — a critical mineral used in flame retardants, batteries, and industrial applications — with operations in the U.S. and Mexico. As one of the few North American antimony sources, UAMY occupies a strategic niche in a market increasingly focused on supply chain security for critical materials.
UAMY will report Q1 2026 results after the close on May 14, 2026. Analysts expect an EPS loss of $0.02 on two estimates, with a consensus range from -$0.02 to -$0.02. The company most recently reported Q4 2025 EPS of -$0.01 on March 19, 2026, which met the consensus estimate of -$0.01. Comparing to the same quarter last year, Q1 2025 delivered EPS of $0.00, meaning the current estimate implies continued pressure year-over-year.
Three key themes define this earnings story:
1. Production Ramp and Cost Management: Investors will scrutinize production volumes in metric tons of antimony and gold, average realized sales prices, and cost per ton across UAMY's operations. After Q3 2025's sharp -$0.04 miss and subsequent Q4 stabilization, the market needs evidence that the company can scale output profitably and control operating expenses as it ramps production.
2. Revenue Growth Trajectory: With full-year 2026 revenue estimates projecting dramatic growth — analysts forecast $124.84 million for 2026 versus prior-year comparisons showing triple-digit percentage increases in recent quarters — the question is whether Q1 can deliver sequential improvement. Q4 2025 revenue of $13.03 million beat estimates by 7.35%, but Q3's 33.66% revenue miss remains a cautionary data point.
3. Strategic Positioning in Critical Minerals: As antimony gains recognition as a U.S. government-designated critical mineral, any commentary on long-term supply agreements, partnerships with battery or energy companies, or regulatory developments could significantly impact investor sentiment. Management's outlook on global antimony pricing and demand visibility will be closely watched for signals about the company's long-term sustainability.
Analyst commentary ahead of the release reflects cautious optimism tempered by execution concerns. With 3 Strong Buy ratings and 1 Hold among the 4 analysts covering the stock, the consensus leans bullish with a mean price target of $12.67 — implying 27% upside from current levels. However, the wide range of full-year 2026 EPS estimates (from -$0.21 to $0.17) underscores significant uncertainty about the company's ability to achieve profitability this year.
Part 2: Historical Earnings Performance
UAMY's recent earnings history reveals a troubling pattern of consistent disappointments followed by a recent stabilization. Over the past four quarters, the company has missed or met estimates in every report, with no beats during this period.
The trend deteriorated sharply in mid-2025: Q1 2025 delivered $0.00 versus a $0.01 estimate (-100% surprise), Q2 2025 repeated the pattern with $0.00 against a $0.01 estimate (-100% surprise), and Q3 2025 marked the low point with -$0.04 against a $0.02 estimate (-300% surprise). This Q3 miss represented a significant operational setback, with the company swinging from breakeven to a meaningful loss while analysts had expected modest profitability.
The most recent quarter showed stabilization rather than improvement: Q4 2025 reported -$0.01, exactly matching the consensus estimate of -$0.01 (unchanged). While meeting expectations ended the string of negative surprises, the company remained unprofitable and failed to demonstrate the operational inflection point investors are seeking. This pattern of persistent losses despite meeting lowered expectations raises questions about whether UAMY can achieve the profitability trajectory embedded in 2026 and 2027 analyst forecasts.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $0.01 | $0.00 | -100.00% | Miss |
| Jun 2025 | $0.01 | $0.00 | -100.00% | Miss |
| Sep 2025 | $0.02 | $-0.04 | -300.00% | Miss |
| Dec 2025 | $-0.01 | $-0.01 | unch | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
UAMY typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-03-19 | -$0.23 (-2.46%) | $0.59 (6.37%) | -$0.95 (-10.43%) | $1.96 (21.51%) |
| 2025-11-12 | -$0.45 (-5.58%) | $0.71 (8.76%) | -$0.43 (-5.64%) | $0.99 (12.99%) |
| 2024-11-12 | -$0.06 (-9.38%) | $0.07 (10.04%) | -$0.01 (-1.61%) | $0.04 (5.65%) |
| 2024-04-12 | N/A | N/A | N/A | N/A |
| 2023-11-13 | N/A | N/A | N/A | N/A |
| 2023-10-05 | N/A | N/A | N/A | N/A |
| 2023-07-18 | N/A | N/A | N/A | N/A |
| 2022-05-16 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 5.81% | 8.39% | 5.89% | 13.38% |
Historical price action around earnings shows significant volatility, with the stock averaging absolute moves of 5.81% on Day 0 and 5.89% on Day +1. Intraday ranges are even more dramatic, averaging 8.39% on Day 0 and 13.38% on Day +1, indicating substantial two-way price swings as investors digest results.
The most recent earnings events illustrate this pattern: the March 2026 report (Q4 2025) saw the stock decline 2.46% on Day 0 with a 6.37% intraday range, followed by a sharp -10.43% move on Day +1 with a 21.51% range — the largest single-day reaction in the available dataset. The November 2025 report (Q3 2025) produced a -5.58% Day 0 move and -5.64% Day +1 move, with ranges of 8.76% and 12.99% respectively. This recent history suggests investors should prepare for potential double-digit percentage swings in either direction following tomorrow's release.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 2) |
| Expected Move | $0.95 (9.53%) |
| Expected Range | $9.04 to $10.94 |
| Implied Volatility | 194.12% |
The options market is pricing an expected move of 9.53% (±$0.95) through the May 15 expiration, which is notably higher than the historical average Day +1 move of 5.89% but lower than the average Day +1 range of 13.38%. This suggests options traders are anticipating above-average volatility but not the extreme swings seen in the most recent March 2026 earnings reaction.
Part 3: What Analysts Are Saying
Analyst sentiment on UAMY remains constructive but cautious, with the consensus leaning bullish despite recent execution challenges. The current rating breakdown shows 3 Strong Buy recommendations and 1 Hold, producing an average rating of 4.50 on the 5-point scale — a solidly bullish stance. Over the past month, this consensus has remained unchanged, indicating analysts are maintaining their positive outlook despite the stock's recent volatility.
The mean price target of $12.67 implies 27% upside from the current price of $9.97, with individual targets ranging from a low of $11.50 to a high of $13.50. This relatively tight range suggests analysts share a similar view on the company's fair value, though the path to reaching those targets depends heavily on operational execution.
Looking at earnings expectations, the analyst community shows significant divergence on the company's profitability trajectory. For full-year 2026, the average EPS estimate of $0.03 masks a wide range from -$0.21 to $0.17 among three analysts — a spread that reflects fundamental uncertainty about whether UAMY can achieve profitability this year. The outlook improves dramatically for 2027, with analysts projecting $0.31 per share (range: $0.13 to $0.49), implying 933% growth if the company can execute on its production ramp and cost management initiatives.
Part 4: Technical Picture
UAMY enters earnings with a mixed technical picture that reflects recent momentum gains tempered by short-term weakness. The Barchart Technical Opinion currently stands at 88% Buy, down from 100% Buy one week ago but unchanged from one month ago, indicating some recent softness after a period of strength.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal suggests near-term momentum has cooled considerably from recent highs, reflecting the stock's pullback from the $11+ levels seen in recent sessions
- Medium-term (100% Buy): Strong buy signal indicates the intermediate-term trend remains firmly positive, supporting the view that the recent decline is a consolidation within an uptrend
- Long-term (100% Buy): Strong buy signal confirms the broader trend structure is bullish, with the stock well above its longer-term moving averages
Trend Characteristics: The overall trend shows Average strength but is Weakening, suggesting momentum has peaked in the near term and the stock may be vulnerable to further downside if earnings disappoint.
The stock's relationship to key moving averages reveals this tension: UAMY trades above its 50-day ($9.89), 100-day ($8.86), and 200-day ($7.75) moving averages, confirming the longer-term uptrend remains intact. However, the current price sits below the 5-day ($10.56), 10-day ($11.25), and 20-day ($10.83) averages, indicating recent selling pressure has pushed the stock into a short-term downtrend.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $10.56 | 50-Day MA | $9.89 |
| 10-Day MA | $11.25 | 100-Day MA | $8.86 |
| 20-Day MA | $10.83 | 200-Day MA | $7.75 |
Key technical levels to watch include the 50-day moving average at $9.89, which now serves as immediate support just below the current price, and the 20-day average at $10.83, which represents the first resistance level the stock must reclaim to resume its uptrend. The setup heading into earnings is cautiously supportive — the longer-term trend structure remains bullish and the stock has pulled back to a logical support zone, potentially offering a favorable risk/reward entry point if results exceed expectations. However, the weakening momentum and position below short-term averages mean a disappointing report could trigger a test of the 50-day support, with the 100-day average at $8.86 representing the next meaningful floor if selling accelerates.